Latest News

  • JP Morgan Notes on Research Services, OTC Testing, Cell-Free Testing

    Diagnostics World News | At the JP Morgan Healthcare Conference—being held virtually again this year—diagnostics companies gave overviews of their 2021 business and their views of the future. Here are the highlights we noted from presentations from Thermo Fisher Scientific, Abbott, and Natera.

    Jan 17, 2022
  • Bioimpedance Test For Breast Cancer Could Hit The Market In 2023

    Diagnostics World News | Mammography has a lot of well-recognized shortcomings among women with dense breasts as well as those diagnosed with breast cancer who need their response to therapy closely monitored. A cheaper, noninvasive, and easy-to-perform test is now under development that could solve for its clinical limitations and is on track to hit the market as early as 2023.

    Jan 13, 2022
  • Illumina’s Diagnostic Vision

    Diagnostics World | Speaking at the 2022 JP Morgan Healthcare Conference—being held virtually again this year—deSouza, the CEO of Illumina, outlined the sequencing giant’s plans for expanding their diagnostic capabilities and business.

    Jan 11, 2022
  • Trendspotting: Top Diagnostics Issues in 2022

    Diagnostics World News | We spoke with the vendor community of Diagnostics World to gather predictions for the coming year. They gave us additional forecasts for imaging data infrastructures, staffing shortage remedies, SaaS medical devices, avoiding bias in AI algorithms, and more.

    Jan 10, 2022
  • ‘Designer Biosensors’ Proposed For Measuring Patient Response To Toxic Drugs

    Diagnostics World News | Researchers in Australia have succeeded in building a chemically induced dimerization (CID) system that can detect the concentration of the antimetabolite drug methotrexate in serum. Coupled with a functionally related biosensor of rapamycin, commonly used to prevent organ transplant rejection, they also looked at lab prototypes of a multiplexed bioelectronic system for repeated measurements of multiple analytes.

    Jan 6, 2022
  • Monitoring Pregnancy Progress With RNA Profiling

    Diagnostics World | A global collaborative of researchers has used a novel platform based on cell-free RNA (cfRNA) to monitor patterns of gene expression as pregnancy progresses—including, surprisingly, genes that appear to originate with the developing fetus. They recently demonstrated the platform’s potential as a pregnancy screening tool, using preeclampsia as a test case, but it might logically also be brought to bear in the future treatment and prevention of any number of pregnancy-related complications.

    Jan 5, 2022
  • Skin Cholesterol Testing Could Play Role In Lipid Screening and Management

    Diagnostics World | Researchers in China have developed a noninvasive skin cholesterol detection system that could be useful in the long-term lipid management of cardiovascular diseases, meeting a critical unmet need.

    Jan 4, 2022
  • Follow the Money: Blood Collection Technology, SPR-Based Proteomics, Maternal Health, Immune Organoids, More

    Diagnostics World News | Technologies for blood collection and testing, immune-competent organoids, flow cytometry for cell therapies, and SPR-based proteomics

    Dec 28, 2021
  • Top Stories of 2021: Scratch-and-Sniff COVID-19 Tests, Outlook for EUA Products, New Approaches for Assessing Biological Age

    Diagnostics World News | With vaccines becoming widely available, there was still a need to expand testing capabilities, bringing these efforts right into the home with over-the-counter tests and thinking outside of the box with cheap smell-based testing. We also learned more about the process for various tests and interventions to transition from EUA to full approval, or why they might be abandoned.

    Dec 27, 2021
  • PacBio’s Precision Health Partnership, AI-Powered Diagnostics, New Patents, More

    Diagnostics World | Diagnostics partnerships on scalp-sensing electrodes, AI-powered pathology, and devices in China. Plus new products from Leica Microsystems, Foundation Medicine, PerkinElmer, more.

    Dec 22, 2021
  • DIY Artificial Pancreas Gaining Widespread Clinical Support

    Diagnostics World News | People with type 1 diabetes face unique challenges in managing their disease, including, for many decades, the need to review their blood sugar levels and adjust insulin dosing by hand. Creation of an artificial pancreas system connecting glucose sensors and insulin pumps introduced automation, the technology has not been routinely available. Online peer communities filled this gap by engineering sophisticated, do-it-yourself solutions.

    Dec 21, 2021
  • Nautilus Biotechnology Taking Protein Analysis To The Single-Molecule Level

    Bio-IT World | A growing number of companies are endeavoring to replicate the success of gene sequencing juggernaut Illumina in the burgeoning field of proteomics. A top contender is Nautilus Biotechnology, which has spent the past few years drumming up excitement about the potential for comprehensively profiled proteins to make therapeutic and diagnostic development more effective and time efficient.

    Dec 16, 2021
  • Virtual Histology Moving Closer To Clinical Adoption

    Diagnostics World News | Histopathology is destined to go through the same sort of digital transformation that occurred in the home entertainment industry with the wholesale switchover from in-person visits at Blockbuster stores to anytime movie availability from streaming service Netflix.

    Dec 14, 2021
  • Harvard and MIT Researchers Pursue Improved RNA and Cellular Therapies with eToehold Technology

    Diagnostics World | A group of cell engineers and synthetic biologists at Harvard University and Massachusetts Institute of Technology (MIT) has developed a tech tool called “eToeholds” that could help improve the safety and efficacy of RNA and cell therapies, in addition to enabling new forms of detection.

    Dec 9, 2021
  • Liquid Biopsy in the Field: Oxford Nanopore’s Chemistry, Hardware Plans

    Diagnostics World News | At Oxford Nanopore’s virtual Community Meeting last week, CTO Clive Brown presented new sequencing chemistries and hardware to enable liquid biopsy in the field.

    Dec 6, 2021
  • Follow the Money: Skincare Diagnostics, Gynecological Imaging

    Diagnostics World News | American Rescue Plan investment for diagnostics manufacturing, point-of-care gynecological imaging, skincare diagnostics, sepsis diagnostics for warfighters, and more.

    Dec 2, 2021
  • Big Money for French AI Startup, Illumina Powers Canadian COVID-19 Network, More

    Diagnostics World News | French AI startup Owkin announces big funding and Memorial Sloan Kettering Cancer Center partnership, Roche and Genentech choose Flywheel cloud informatics, and Talis Biomedical gets FDA EUA for COVID-19 test. Plus new products from VIDA Diagnostics, Oncocyte, Metabolon and more.

    Nov 30, 2021
  • Illumina, Genetic Alliance Launch iHope Genetic Health for Whole Genome Sequencing

    Diagnostics World | Illumina and Genetic Alliance announced this week the creation of the iHope Genetic Health program aimed at providing whole-genome sequencing access (WGS) to tens of thousands of patients across the globe impacted by genetic disease. At least half of iHope Genetic Health's efforts will be focused on areas of the world in need outside the US, with more than one-third of Illumina's support being dedicated to patients in Africa.

    Nov 22, 2021
  • New Virus Panel Detects Coinfections—And Could Inform Development Of COVID Boosters

    Diagnostics World News | Labs around the country with next-generation sequencing capabilities have begun using a respiratory virus panel that simultaneously tests for SARS-CoV-2 and 40 other potentially co-occurring respiratory viruses, including four cold-causing coronaviruses, both types of respiratory syncytial viruses (RSV), and more than a dozen influenza viruses.

    Nov 17, 2021
  • Geisinger Looks to Develop Tool for Genetic Disorders, Shorten Diagnostic Odysseys

    Diagnostics World News| Geisinger researchers have been awarded a $5 million grant to develop a diagnostic tool for genetic disorders. With support from the National Institutes of Health’s National Human Genome Research Institute, the group plans to build a High Impact Phenotype Identification System. The aim is to trim the time between symptom onset and the discovery of a genetic basis to improve patient care and outcomes.

    Nov 15, 2021